Jennifer S. Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jennifer S. Lin has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Evelyn P. Whitlock
Oregon Evidence-Based Practice Center
5 shared publications Sarah I. Bean
Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon
5 shared publicationsElizabeth M. Webber
Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon
4 shared publicationsCorinne V. Evans
Kaiser Permanente Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon
3 shared publicationsNing Smith
Kaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente, Portland, Oregon
3 shared publicationsAllea M. Martin
Kaiser Permanente Evidence-based Practice Center, Kaiser Permanente Center for Health Research, Portland, OR, United States
2 shared publications
Latest Publications
- 4 March 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (3) , e241875
Development of a Health Equity Framework for the US Preventive Services Task Force
Health equity refers to the absence of unjust, avoidable, or remediable differences in health and well-being among groups of people.1 Unlike health equality, which focuses solely on equal access to quality health care for all, equity requires the application of proportionate universalism. This means providing universal services at a scale and intensity that matches the level of need, ensuring that everyone can attain their maximum potential for health and well-being.2
- 4 March 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (3) , e241875
Development of a Health Equity Framework for the US Preventive Services Task Force
Health equity refers to the absence of unjust, avoidable, or remediable differences in health and well-being among groups of people.1 Unlike health equality, which focuses solely on equal access to quality health care for all, equity requires the application of proportionate universalism. This means providing universal services at a scale and intensity that matches the level of need, ensuring that everyone can attain their maximum potential for health and well-being.2
- Open Access
- 29 March 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1098431
Rapid evidence review: Policy actions for the integration of public health and health care in the United States
Objective: To identify policy actions that may improve the interface of public health and health care in the United States.Methods: A rapid review of publicly-available documents informing the integration of public health and health care, and case examples reporting objective measures of success, with abstraction of policy actions, related considerations, and outcomes.Results: Across 109 documents, there were a number of recurrent themes related to policy actions and considerations to facilitate integration during peace time and during public health emergencies. The themes could be grouped into the need for adequate and dedicated funding; mandates and shared governance for integration; joint leadership that has the authority/ability to mobilize shared assets; adequately staffed and skilled workforces in both sectors with mutual awareness of shared functions; shared health information systems with modernized data and IT capabilities for both data collection and dissemination of information; engagement with multiple stakeholders in the community to be maximally inclusive; and robust communication strategies and training across partners and with the public.Conclusion: While the evidence does not support a hierarchy of policies on strengthening the interface of public health and health care, recurrent policy themes can inform where to focus efforts.
- 29 March 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1098431
Open AccessRapid evidence review: Policy actions for the integration of public health and health care in the United States
Objective: To identify policy actions that may improve the interface of public health and health care in the United States.Methods: A rapid review of publicly-available documents informing the integration of public health and health care, and case examples reporting objective measures of success, with abstraction of policy actions, related considerations, and outcomes.Results: Across 109 documents, there were a number of recurrent themes related to policy actions and considerations to facilitate integration during peace time and during public health emergencies. The themes could be grouped into the need for adequate and dedicated funding; mandates and shared governance for integration; joint leadership that has the authority/ability to mobilize shared assets; adequately staffed and skilled workforces in both sectors with mutual awareness of shared functions; shared health information systems with modernized data and IT capabilities for both data collection and dissemination of information; engagement with multiple stakeholders in the community to be maximally inclusive; and robust communication strategies and training across partners and with the public.Conclusion: While the evidence does not support a hierarchy of policies on strengthening the interface of public health and health care, recurrent policy themes can inform where to focus efforts.
- Open Access
- 10 May 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 327 (18) , 1812-1816
Screening for Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is defined by a reduction in airflow that is not entirely reversible. COPD remains a leading cause of morbidity and mortality in the US.1 The major risk factor for developing COPD and COPD mortality is exposure to smoke or fumes, notably direct or indirect exposure to cigarette smoke, and occupational or environmental exposures (eg, pollutants, wood smoke).2 Many patients with COPD go undetected for multiple reasons, including underrecognition of mild symptoms (eg, dyspnea) or nonspecific symptoms (eg, fatigue). Screening or active case finding (ie, spirometry based on systematically assessing for symptoms, risk factors, or both) for COPD can detect persons otherwise not diagnosed as part of routine care; however, it is yet unclear if increased detection of persons with unrecognized symptoms improves patient health outcomes.
- 10 May 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 327 (18) , 1812-1816
Open AccessScreening for Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is defined by a reduction in airflow that is not entirely reversible. COPD remains a leading cause of morbidity and mortality in the US.1 The major risk factor for developing COPD and COPD mortality is exposure to smoke or fumes, notably direct or indirect exposure to cigarette smoke, and occupational or environmental exposures (eg, pollutants, wood smoke).2 Many patients with COPD go undetected for multiple reasons, including underrecognition of mild symptoms (eg, dyspnea) or nonspecific symptoms (eg, fatigue). Screening or active case finding (ie, spirometry based on systematically assessing for symptoms, risk factors, or both) for COPD can detect persons otherwise not diagnosed as part of routine care; however, it is yet unclear if increased detection of persons with unrecognized symptoms improves patient health outcomes.
- Open Access
- 21 December 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 326 (23) , 2412-2420
Addressing Racism in Preventive Services
In 2020, following the deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, the US Preventive Services Task Force (USPSTF) established a Race and Racism work group. This work group issued a values statement for the USPSTF that directly acknowledged that systemic racism prevents many people of color from fully benefiting from their recommended clinical preventive services and also denounced racism in all forms against any group of people.1 As part of this statement, the USPSTF made commitments to address racism and health equity. In support of these commitments, this methods study was conducted to help the USPSTF understand how racism may be preventing it from achieving its prevention goals and how to evolve the USPSTF reports to more directly address racism and health inequities by race and ethnicity.
- 21 December 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 326 (23) , 2412-2420
Open AccessAddressing Racism in Preventive Services
In 2020, following the deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, the US Preventive Services Task Force (USPSTF) established a Race and Racism work group. This work group issued a values statement for the USPSTF that directly acknowledged that systemic racism prevents many people of color from fully benefiting from their recommended clinical preventive services and also denounced racism in all forms against any group of people.1 As part of this statement, the USPSTF made commitments to address racism and health equity. In support of these commitments, this methods study was conducted to help the USPSTF understand how racism may be preventing it from achieving its prevention goals and how to evolve the USPSTF reports to more directly address racism and health inequities by race and ethnicity.
- Top Cited PapersOpen Access
- 18 May 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (19) , 1978-1997
Screening for Colorectal Cancer
Although the incidence of colorectal cancer (CRC) has declined over time, it remains a significant cause of morbidity and mortality in the US. Among all cancers, it is third in incidence and cause of cancer death for both men and women.1 In addition, cohort trends indicate that CRC incidence is decreasing only for persons 55 years or older.2 From the mid-1990s until 2013 the incidence of CRC had increased annually by 0.5% to 1.3% in adults aged 40 to 54 years.2
- 18 May 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (19) , 1978-1997
Top Cited PapersOpen AccessScreening for Colorectal Cancer
Although the incidence of colorectal cancer (CRC) has declined over time, it remains a significant cause of morbidity and mortality in the US. Among all cancers, it is third in incidence and cause of cancer death for both men and women.1 In addition, cohort trends indicate that CRC incidence is decreasing only for persons 55 years or older.2 From the mid-1990s until 2013 the incidence of CRC had increased annually by 0.5% to 1.3% in adults aged 40 to 54 years.2
- 1 April 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (6) , 1830-1835
A Narrative Review and Proposed Framework for Using Health System Data with Systematic Reviews to Support Decision-making
Systematic reviews are a necessary, but often insufficient, source of information to address the decision-making needs of health systems. In this paper, we address when and how the use of health system data might make systematic reviews more useful to decision-makers. We describe the different ways in which health system data can be used with systematic reviews, identify scenarios in which the addition of health system data may be most helpful (i.e., to improve the strength of evidence, to improve the applicability of evidence, and to inform the implementation of evidence), and discuss the importance of framing the limitations and considerations when using unpublished health system data in reviews. We developed a framework to guide the use of health system data alongside systematic reviews based on a narrative review of the literature and empirical experience. We also offer recommendations to improve the transparency of reporting when using health system data alongside systematic reviews including providing rationale for employing additional data, details on the data source, critical appraisal to understand study design biases as well as limitations in data and information quality, and how the unpublished data compares to the systematically reviewed data. Future methodological work on how best to handle internal and external validity concerns of health system data in the context of systematically reviewed data and work on developing infrastructure to do this type of work is needed.
- 1 April 2020
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (6) , 1830-1835
A Narrative Review and Proposed Framework for Using Health System Data with Systematic Reviews to Support Decision-making
Systematic reviews are a necessary, but often insufficient, source of information to address the decision-making needs of health systems. In this paper, we address when and how the use of health system data might make systematic reviews more useful to decision-makers. We describe the different ways in which health system data can be used with systematic reviews, identify scenarios in which the addition of health system data may be most helpful (i.e., to improve the strength of evidence, to improve the applicability of evidence, and to inform the implementation of evidence), and discuss the importance of framing the limitations and considerations when using unpublished health system data in reviews. We developed a framework to guide the use of health system data alongside systematic reviews based on a narrative review of the literature and empirical experience. We also offer recommendations to improve the transparency of reporting when using health system data alongside systematic reviews including providing rationale for employing additional data, details on the data source, critical appraisal to understand study design biases as well as limitations in data and information quality, and how the unpublished data compares to the systematically reviewed data. Future methodological work on how best to handle internal and external validity concerns of health system data in the context of systematically reviewed data and work on developing infrastructure to do this type of work is needed.
- Open Access
- 4 September 2018
- Published by American Medical Association (AMA) in JAMA
- Vol. 320 (9) , 918-925
Screening for Syphilis Infection in Pregnant Women
In the United States, the rate of reported congenital syphilis was 15.7 cases per 100 000 live births in 2016, the highest rate reported since 2001.1,2 Congenital syphilis is an infectious disease caused by the vertical transmission of Treponema pallidum; thus, prevention and detection of congenital syphilis depend on the identification of syphilis in pregnant women. Two screening protocols are commonly used: the traditional screening algorithm (ie, nontreponemal testing with reflex to treponemal testing) and the reverse sequence screening algorithm (ie, treponemal testing with reflex to nontreponemal testing) (Figure 1).3,4 Untreated syphilis in pregnancy carries significant risk for stillbirth or fetal loss, premature birth, low birthweight, congenital syphilis, and neonatal death.5,6 Parenteral benzathine penicillin G is the only recommended antibiotic for preventing maternal transmission of syphilis to the fetus and treating fetal syphilis infection.7 This evidence review was completed to inform the US Preventive Services Task Force (USPSTF) in the update to its 2009 “A” recommendation to screen all pregnant women for syphilis.8,9
- 4 September 2018
- Published by American Medical Association (AMA) in JAMA
- Vol. 320 (9) , 918-925
Open AccessScreening for Syphilis Infection in Pregnant Women
In the United States, the rate of reported congenital syphilis was 15.7 cases per 100 000 live births in 2016, the highest rate reported since 2001.1,2 Congenital syphilis is an infectious disease caused by the vertical transmission of Treponema pallidum; thus, prevention and detection of congenital syphilis depend on the identification of syphilis in pregnant women. Two screening protocols are commonly used: the traditional screening algorithm (ie, nontreponemal testing with reflex to treponemal testing) and the reverse sequence screening algorithm (ie, treponemal testing with reflex to nontreponemal testing) (Figure 1).3,4 Untreated syphilis in pregnancy carries significant risk for stillbirth or fetal loss, premature birth, low birthweight, congenital syphilis, and neonatal death.5,6 Parenteral benzathine penicillin G is the only recommended antibiotic for preventing maternal transmission of syphilis to the fetus and treating fetal syphilis infection.7 This evidence review was completed to inform the US Preventive Services Task Force (USPSTF) in the update to its 2009 “A” recommendation to screen all pregnant women for syphilis.8,9
- Open Access
- 17 July 2018
- Published by American Medical Association (AMA) in JAMA
- Vol. 320 (3) , 281-297
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment
Cardiovascular disease (CVD) is the leading cause of death in the United States, accounting for about 1 in 3 deaths.1 The incidence of CVD is strongly associated with a set of traditional risk factors,2-5 which have been combined using multivariable risk assessment tools to estimate an individual’s risk for having a CVD event.6 However, these tools can underestimate or overestimate CVD risk.7 Inclusion of nontraditional biological and physiologic risk factors might improve the performance of tools. Given that risk estimates are used to guide preventive therapy such as aspirin and statins,6,8-10 improved risk assessment performance could result in improved CVD outcomes.
- 17 July 2018
- Published by American Medical Association (AMA) in JAMA
- Vol. 320 (3) , 281-297
Open AccessNontraditional Risk Factors in Cardiovascular Disease Risk Assessment
Cardiovascular disease (CVD) is the leading cause of death in the United States, accounting for about 1 in 3 deaths.1 The incidence of CVD is strongly associated with a set of traditional risk factors,2-5 which have been combined using multivariable risk assessment tools to estimate an individual’s risk for having a CVD event.6 However, these tools can underestimate or overestimate CVD risk.7 Inclusion of nontraditional biological and physiologic risk factors might improve the performance of tools. Given that risk estimates are used to guide preventive therapy such as aspirin and statins,6,8-10 improved risk assessment performance could result in improved CVD outcomes.
- 1 January 2018
Screening for Adolescent Idiopathic Scoliosis: A Systematic Evidence Review for the U.S. Preventive Services Task Force
Scoliosis is a lateral curvature of the spine of 10° or more, often with a rotational component; adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis in adolescence. Curves progress in approximately two-thirds of AIS patients before they reach skeletal maturity. Curves of greater than 40° at the end of growth are likely to continue to progress after skeletal maturity, while curves of less than 30° at skeletal maturity are unlikely to progress significantly during adulthood. Very large degrees of curvature may be associated with adverse long-term health outcomes. The U.S. Preventive Services Task Force will use this evidence review to update its 2004 recommendation on screening for AIS. Cochrane Central Register of Controlled Trials, OVID Medline, ERIC (Eric.ed.gov), PubMed (publisher-supplied), Cumulative Index to Nursing and Allied Health Literature, and relevant systematic reviews. We searched for articles published from January 1966 to October 31, 2015. We updated our search on October 20, 2016. Two reviewers independently reviewed 8,230 titles and abstracts and 1,088 articles against prespecified inclusion criteria, resolving discrepancies through consensus. We included fair- or good-quality studies. For screening questions (Key Questions [KQs] 1, 2, and 5), the population of interest was asymptomatic children ages 10 to 18 years, screened in primary care–referable settings using the forward bend test (FBT) with or without a scoliometer, surface topography, or other methods. For treatment questions (KQs 3 and 6), we included studies of children and adolescents ages 10 to 18 years diagnosed with AIS with a Cobb angle of 10° to 50° at detection. For long-term outcomes (KQ 4), we included randomized, controlled trials (RCTs), controlled trials, or large observational studies of adult health outcomes in persons diagnosed with AIS with a Cobb angle of 10° or greater. We extracted key elements of included studies into standardized evidence tables. Evidence tables were tailored for each KQ and to specific study designs. We provided a narrative synthesis of results. Because of heterogeneity between studies, we did not conduct pooling or meta-analyses. We included seven studies (13 articles) on screening accuracy (KQ 2), seven studies (nine articles) on the effectiveness of treatment (KQ 3), one study (two articles) on the harms of treatment (KQ 6), and two studies (five articles) on long-term outcomes (KQ 4). No studies met our inclusion criteria on the effect of AIS screening on long-term health outcomes (KQ 1) or on the harms of screening (KQ 5). KQ 1. Does screening for AIS improve: a) health outcomes, and b) the degree of abnormal spinal curvature in childhood or adulthood? No studies. KQ 2. What is the accuracy of screening for AIS? Seven fair-quality screening programs (13 articles) including 447,243 adolescents met our inclusion criteria. Six of the seven programs were conducted in school settings, and there...
- 1 January 2018
Screening for Adolescent Idiopathic Scoliosis: A Systematic Evidence Review for the U.S. Preventive Services Task Force
Scoliosis is a lateral curvature of the spine of 10° or more, often with a rotational component; adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis in adolescence. Curves progress in approximately two-thirds of AIS patients before they reach skeletal maturity. Curves of greater than 40° at the end of growth are likely to continue to progress after skeletal maturity, while curves of less than 30° at skeletal maturity are unlikely to progress significantly during adulthood. Very large degrees of curvature may be associated with adverse long-term health outcomes. The U.S. Preventive Services Task Force will use this evidence review to update its 2004 recommendation on screening for AIS. Cochrane Central Register of Controlled Trials, OVID Medline, ERIC (Eric.ed.gov), PubMed (publisher-supplied), Cumulative Index to Nursing and Allied Health Literature, and relevant systematic reviews. We searched for articles published from January 1966 to October 31, 2015. We updated our search on October 20, 2016. Two reviewers independently reviewed 8,230 titles and abstracts and 1,088 articles against prespecified inclusion criteria, resolving discrepancies through consensus. We included fair- or good-quality studies. For screening questions (Key Questions [KQs] 1, 2, and 5), the population of interest was asymptomatic children ages 10 to 18 years, screened in primary care–referable settings using the forward bend test (FBT) with or without a scoliometer, surface topography, or other methods. For treatment questions (KQs 3 and 6), we included studies of children and adolescents ages 10 to 18 years diagnosed with AIS with a Cobb angle of 10° to 50° at detection. For long-term outcomes (KQ 4), we included randomized, controlled trials (RCTs), controlled trials, or large observational studies of adult health outcomes in persons diagnosed with AIS with a Cobb angle of 10° or greater. We extracted key elements of included studies into standardized evidence tables. Evidence tables were tailored for each KQ and to specific study designs. We provided a narrative synthesis of results. Because of heterogeneity between studies, we did not conduct pooling or meta-analyses. We included seven studies (13 articles) on screening accuracy (KQ 2), seven studies (nine articles) on the effectiveness of treatment (KQ 3), one study (two articles) on the harms of treatment (KQ 6), and two studies (five articles) on long-term outcomes (KQ 4). No studies met our inclusion criteria on the effect of AIS screening on long-term health outcomes (KQ 1) or on the harms of screening (KQ 5). KQ 1. Does screening for AIS improve: a) health outcomes, and b) the degree of abnormal spinal curvature in childhood or adulthood? No studies. KQ 2. What is the accuracy of screening for AIS? Seven fair-quality screening programs (13 articles) including 447,243 adolescents met our inclusion criteria. Six of the seven programs were conducted in school settings, and there...
- Open Access
- 1 January 2018
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 54 (1) , S26-S37
Framework for Using Risk Stratification to Improve Clinical Preventive Service Guidelines
- 1 January 2018
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 54 (1) , S26-S37
Open AccessFramework for Using Risk Stratification to Improve Clinical Preventive Service Guidelines